| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000856A3 Protein glycosylation modification in pichia pastoris |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001098331A3 Glucagon-like peptide-1 analogs |
| 01/03/2003 | WO2001096370A3 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 01/03/2003 | WO2001083819A9 Methods for designing exogenous regulatory molecules |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001075068A3 Secreted proteins and polynucleotides encoding them |
| 01/03/2003 | WO2001073087A8 Cestrum yellow leaf curling virus promoters |
| 01/03/2003 | WO2001068910A3 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner |
| 01/03/2003 | WO2001064891A9 Nucleotide sequences for embryo and/or endosperm specific expression in plants |
| 01/03/2003 | WO2001060972A3 Novel peptides and methods of use |
| 01/03/2003 | WO2001057272A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 01/03/2003 | WO2001057251A3 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2724316A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724188A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724166A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724158A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2460809A1 Polynucleotide vaccine |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2454882A1 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | CA2452602A1 Compositions and methods for modulating plant development |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451380A1 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451310A1 Antimicrobial peptides |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451247A1 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450950A1 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450783A1 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | CA2447941A1 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | CA2447249A1 Abin-mediated hepatitis protection |
| 01/03/2003 | CA2446218A1 Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| 01/03/2003 | CA2442710A1 Human secreted proteins |
| 01/03/2003 | CA2427798A1 Testis protein, zsig86 |
| 01/02/2003 | US20030005491 Propagation of diseases resistant plants; obtain plants, mate, recover plants, screen for nematode resistance, recover and propagate plants with nematode resistance |
| 01/02/2003 | US20030005487 Detection of plants with amplified chaperone activity; obtain plant, heat plant, monitor expression of chaperone proteins in cells |
| 01/02/2003 | US20030005485 Nucleotide sequences coding polypeptide for use the generation of disease resistant plants |
| 01/02/2003 | US20030005480 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 01/02/2003 | US20030005476 Transgenic rodent for as tool in he diagnosis and treatment of nervous system disorders and epilepsy |
| 01/02/2003 | US20030005471 PAR, a novel marker gene for breast and prostate cancers |
| 01/02/2003 | US20030004328 Controlling phosphorylation |
| 01/02/2003 | US20030004327 Cerebellum and embryo specific protein |
| 01/02/2003 | US20030004326 Fungicides |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004323 Novel antigen constructs useful in the detection and differention of antibodies to hiv |
| 01/02/2003 | US20030004320 Activated peptides and conjugates |
| 01/02/2003 | US20030004319 Wound healing agent |
| 01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
| 01/02/2003 | US20030004316 Fractionation of whey proteins by complex formation |
| 01/02/2003 | US20030004315 Collagen |
| 01/02/2003 | US20030004314 Autoimmune diseases; rheumatic disorders |
| 01/02/2003 | US20030004313 Apo-3 polypeptide |
| 01/02/2003 | US20030004312 Antiseptics; acidity pH; destroying infections |
| 01/02/2003 | US20030004311 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004309 Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004209 Anti-angiogenic compositions and methods of use |
| 01/02/2003 | US20030004133 Wound healing agents, antiulcer agents |
| 01/02/2003 | US20030004125 Controlling gene expression; antitumor agent |
| 01/02/2003 | US20030004124 Modulation of apoptosis with nucleic acids; anticancer agents, central nervous system disorders |
| 01/02/2003 | US20030004123 Targeted gene transfer using G protein coupled receptors |
| 01/02/2003 | US20030004121 Supplying hybrid protein to central nervous system |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004112 Cell-permeable protein inhibitors of calpain |
| 01/02/2003 | US20030004109 Leptin/ob receptor having a WSX motif |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004101 Alzheimer's disease |
| 01/02/2003 | US20030004098 Polypeptide; purification by chromatography |
| 01/02/2003 | US20030004094 Control of pH transitions during chromatography |
| 01/02/2003 | US20030004092 Methods and agents for inducing apoptosis and methods for their identification |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003564 Modulation of ubiquitin proteolysis; obtain sample containind enzymatic complexes, incubate with sample, monitor cleavage activity |
| 01/02/2003 | US20030003563 Protein crystal of a transcriptional activator for use in drug design and development |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003556 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003544 44576, a novel G-protein coupled receptor and uses therefor |
| 01/02/2003 | US20030003542 ACPL polypeptides |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003539 Nucleotide sequences coding polypeptide for use in the treatment of blood, apoptosis, inflamation and brain disorders |
| 01/02/2003 | US20030003538 Neuropathic pain genes; compositions thereof; related reagents |